Immix Biopharma Inc share price logo

Immix Biopharma Inc Share Price

NASDAQ: IMMX

Small Cap

$6.75

+0.80

(+13.53%)

as on

Immix Biopharma Inc Stock Performance

as on February 7, 2026 at 7:59 am IST

  • Day's Low

    Day's High

    $6.09
    $6.87
    downward going graph

    9.78%

    Downside

    1.78%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $1.34
    $7.73
    downward going graph

    80.15%

    Downside

    14.52%

    Upside

    downward going graph

Immix Biopharma Inc share price movements today

Previous Close
$5.95
Open
$6.09
Volume
1.1M
Day's Low - High
$6.09 - $6.87
52 Week Low - High
$1.34 - $7.73

Immix Biopharma Inc Historical Returns

1 Month Return
+ 33.47 %
3 Month Return
+ 113.97 %
1 Year Return
+ 235.32 %
3 Year Return
+ 134.84 %
5 Year Return
0 %

Immix Biopharma Inc Stock Fundamentals & Key Indicators

Check Immix Biopharma Inc market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$285.4M

EPS (TTM)

-0.645

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

0

PEG Ratio

0

EBITDA

-23.8M

Revenue (TTM)

-

Profit Margin

0.00%

Return On Equity TTM

-182.55%

Immix Biopharma Inc vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Immix Biopharma Inc with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %
Immix Biopharma Inc image
Immix Biopharma Inc
BUY$285.4MNANA0.00%
Vertex Pharmaceuticals Incorporated image
Vertex Pharmaceuticals Incorporated
BUY$122.3B122.02%33.5631.35%
Alnylam Pharmaceuticals, Inc. image
Alnylam Pharmaceuticals, Inc.
BUY$47.7B98.75%1246.031.36%
Beone Medicines Ltd image
Beone Medicines Ltd
NA$37.4BNA662.331.38%
Regeneron Pharmaceuticals, Inc. image
Regeneron Pharmaceuticals, Inc.
BUY$80.8B57.42%18.2832.13%

Stock Returns calculator for Immix Biopharma Inc Stock including INR - Dollar returns

The Immix Biopharma Inc stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

Immix Biopharma Inc investment value today

Current value as on today

₹3,39,130

Returns

₹2,39,130

(+239.13%)

Returns from Immix Biopharma Inc Stock

₹2,35,821 (+235.82%)

Dollar Returns*

₹3,309 (+3.31%)

Analyst Recommendation on Immix Biopharma Inc Stock

Based on 7 analysts

BUY

85.71%

Buy

14.29%

Hold

0.00%

Sell

Based on 7 analysts, 85.71% of analysts recommend a 'BUY' rating for Immix Biopharma Inc. Average target price of $9.6

Immix Biopharma Inc Share Price Target

Get share price movements and forecasts by analysts on Immix Biopharma Inc.

What analysts predicted

29.69%UPSIDE

Target Price

$9.6

Current Price

$6.75

Analyzed by

7 Analysts

Target

$9.60

Immix Biopharma Inc target price $9.6, a slight upside of 29.69% compared to current price of $6.75. According to 7 analysts rating.

Immix Biopharma Inc Stock’s Investor Sentiment and Interest

Search interest for Immix Biopharma Inc Stock has decreased by -32% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-32% versus previous 30 day period

Immix Biopharma Inc Quarterly Profit & Loss

All numbers in Millions USD

Jun 2023
Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Total Revenue
-
-
0
-
-
-
0
-
-
-
Gross Profit
0
0
0
0
0
0
0
0
0
-
Operating Income
-3
-4
-5
-5
-4
-7
-4
-4
-6
-7
EBITDA
-3
-4
-5
-5
-4
-7
-4
-4
-6
-7
Interest Expense
-
-
0
-
-
-
-
-
-
-
Depreciation
0
0
0
0
0
0
0
0
0
0
Income Before Tax
-3
-4
-5
-5
-4
-7
-4
-4
-6
-7
Income Tax Expense
0
0
0
0
0
0
0
0
0
0
Net Income
-3
-4
-5
-5
-4
-7
-4
-4
-6
-7
Net Profit Margin
0.00%
0.00%
-106385.95%
0.00%
0.00%
0.00%
-4997.46%
0.00%
0.00%
0.00%

Immix Biopharma Inc Annual Profit & Loss

All numbers in Millions USD

Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Total Revenue
-
-
-
-89
-
-
Gross Profit
0
0
0
-89
0
0
Operating Income
0
0
-1
-8
-16
-22
EBITDA
0
0
-24
-8
-16
-22
Interest Expense
0
0
0
0
-
-
Depreciation
0
0
0
0
0
0
Income Before Tax
0
-1
-24
-8
-15
-21
Income Tax Expense
0
0
0
0
0
0
Net Income
0
-1
-24
-8
-15
-21
Net Profit Margin
0.00%
0.00%
0.00%
9.19%
0.00%
0.00%

Immix Biopharma Inc Quarterly Cash Flow

All numbers in Millions USD

Sep 2023
Dec 2023
Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Net Income
-4
-5
-5
-4
-7
-4
-4
-6
-7
Operating Cash Flow
-3
-2
-3
-5
-4
-1
-1
-5
-5
Investing Cash Flow
0
0
0
0
0
0
0
0
0
Financing Cash Flow
10
0
15
15
-
-
-
1
10
Change in Cash
6
-2
11
-5
-4
-2
-1
-4
4

Immix Biopharma Inc Annual Cash Flow

All numbers in Millions USD

Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Net Income
-1
-24
-8
-15
-21
Operating Cash Flow
0
-1
-7
-11
-14
Investing Cash Flow
0
0
-
0
-1
Financing Cash Flow
18
18
3
15
15
Change in Cash
0
17
-4
4
0

Global Institutional Holdings in Immix Biopharma Inc

Funds
Holdings
BlackRock Inc
0.14%
The Colony Group LLC
0.04%
SBI Securities Co Ltd
0.06%
Bleichroeder LP
2.95%
Vanguard Group Inc
2.42%
See all

Immix Biopharma Inc News & Key Events

  • img

    Today's Timeline - 07 December

    Mon, 04:50 AM

    -

    Immix Biopharma announces pricing of $100 million stock and warrant offering, expected to close on December 9, 2025.

Insights on Immix Biopharma Inc

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 7 days, IMMX stock has moved up by 15.6%

  • imgPOSITIVE IMPACT

    Best in 1 Year

    img

    In the last 1 year, IMMX has outperformed top 5 stocks with highest market-cap in its industry

  • imgPOSITIVE IMPACT

    Best in 3 Years

    img

    In the last 3 years, IMMX has outperformed top 5 stocks with highest market-cap in its industry

About Immix Biopharma Inc

Immix Biopharma, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on the application of chimeric antigen receptor cell therapy (CAR- T) in light chain (AL) Amyloidosis and select immune-mediated diseases. The Company's lead cell therapy candidate CAR-T NXC-201 (NXC-201), which is being evaluated in its ongoing United States Phase Ib/II NEXICART-2 (NCT06097832) clinical trial. Its lead program, NXC-201 is a next generation CAR-T targeting B-cell maturation antigen. CAR-T cell therapy is a type of immunotherapy that uses the patient’s own immune cells, modified with its proprietary technology. Its N-GENIUS cell engineering platform with EXPAND technology has produced clinical-stage CAR-T NXC-201, targeting B cell maturation antigen, which is autologous CAR-T being developed to treat AL Amyloidosis.
OrganisationImmix Biopharma Inc
Headquarters11400 West Olympic Boulevard, Los Angeles, CA, United States, 90064
CEODr. Ilya Rachman M.B.A., M.D., Ph.D.
E-voting on sharesClick here to vote

Key Management of Immix Biopharma Inc

Name

Title

Dr. Ilya Rachman M.B.A., M.D., Ph.D.

Co-Founder, CEO & Chairman

Mr. Gabriel Morris B.A.

CFO & Director

Dr. Graham Ross FFPM, M.D.

Chief Medical Officer & Head of Clinical Development

Mr. Sean Senn J.D., M.B.A., M.Sc.

Co-Founder

Dr. Vladimir P. Torchilin D.Sc., MSE, Ph.D.

Scientific Co-Founder

Dr. David Marks MBBS, Ph.D.

Chief Medical Officer of Cell Therapy

Mr. Mel Davis-Pickett

Head of CMC Technical Development

Mr. Michael A. Grabow

Chief Commercial Officer

FAQs

What is Immix Biopharma Inc share price today?

Immix Biopharma Inc share price today is $6.75 as on at the close of the market. Immix Biopharma Inc share today touched a day high of $6.87 and a low of $6.09.

What is the 52 week high and 52 week low for Immix Biopharma Inc share?

Immix Biopharma Inc share touched a 52 week high of $7.73 on and a 52 week low of $1.34 on . Immix Biopharma Inc stock price today i.e. is closed at $6.75,which is 12.68% down from its 52 week high and 403.73% up from its 52 week low.

What is Immix Biopharma Inc's market capitalisation today?

Immix Biopharma Inc market capitalisation is $0.00T as on .

How to invest in Immix Biopharma Inc Stock (IMMX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Immix Biopharma Inc on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Immix Biopharma Inc Shares that will get you 0.2222 shares as per Immix Biopharma Inc share price of $6.75 per share as on February 7, 2026 at 2:29 am IST.

What is the minimum amount required to buy Immix Biopharma Inc Stock (IMMX) from India?

Indian investors can start investing in Immix Biopharma Inc (IMMX) shares with as little as ₹90.555 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹905.55 in Immix Biopharma Inc stock (as per the Rupee-Dollar exchange rate as on ). Based on Immix Biopharma Inc share’s latest price of $6.75 as on February 7, 2026 at 2:29 am IST, you will get 1.4815 shares of Immix Biopharma Inc. Learn more about fractional shares .